Results 261 to 270 of about 137,923 (290)
Some of the next articles are maybe not open access.
2003
It is estimated that 56,200 new cases of non-Hodgkin’ s lymphoma (NHL) were diagnosed in the United States in 2001, and approx 26,300 people died from NHL, which makes it the fifth leading cause of cancer death in men and the sixth leading cause of cancer death among women (1).
Igor Espinoza-Delgado, Dan L. Longo
openaire +1 more source
It is estimated that 56,200 new cases of non-Hodgkin’ s lymphoma (NHL) were diagnosed in the United States in 2001, and approx 26,300 people died from NHL, which makes it the fifth leading cause of cancer death in men and the sixth leading cause of cancer death among women (1).
Igor Espinoza-Delgado, Dan L. Longo
openaire +1 more source
Pediatric non-Hodgkin lymphoma
Current Hematologic Malignancy Reports, 2007Non-Hodgkin's lymphoma (NHL) accounts for 7% of cancer in children and adolescents in the United States, or approximately 1000 cases annually. NHL in the pediatric population differs from that observed in adult patients with respect to staging systems, histologic subtypes of disease, treatment, and outcomes.
Thomas G, Gross, Amanda M, Termuhlen
openaire +3 more sources
Intraocular non-Hodgkin's lymphoma
Documenta Ophthalmologica, 1990Usually eye symptoms precede the infiltration of non-Hodgkin's lymphoma in the central nervous system or in other organs. Early treatment of the tumor by irradiation, to which it is highly sensitive, can preserve the vision and prolong the life of the patient.
Hooymans, JMM, Timmerman, Z
openaire +3 more sources
Nursing Standard, 2016
Essential facts Non-Hodgkin's lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. The disease has many subtypes, with two main broad categories: high-grade or aggressive and low-grade or ...
openaire +2 more sources
Essential facts Non-Hodgkin's lymphoma (NHL) is a cancer of the lymphatic system. According to Cancer Research UK, it is the sixth most common cancer in the UK, with 13,413 new cases diagnosed in 2013. There were 4,801 deaths from NHL in 2014. The disease has many subtypes, with two main broad categories: high-grade or aggressive and low-grade or ...
openaire +2 more sources
Current Opinion in Hematology, 1996
Attention is being directed at increasing the intensity of therapy as a means of improving the results of primary therapy for non-Hodgkin's lymphoma. There is increasing evidence that the use of high-dose consolidation therapy followed by autologous hematopoietic rescue in first remission improves survival in high-risk patients.
P J, Bierman, J O, Armitage
openaire +2 more sources
Attention is being directed at increasing the intensity of therapy as a means of improving the results of primary therapy for non-Hodgkin's lymphoma. There is increasing evidence that the use of high-dose consolidation therapy followed by autologous hematopoietic rescue in first remission improves survival in high-risk patients.
P J, Bierman, J O, Armitage
openaire +2 more sources
Endobronchial Non-Hodgkin's Lymphoma
Chest, 1983Four patients with endobronchial non-Hodgkin's lymphoma are presented. Although endobronchial Hodgkin's disease is not uncommon, endobronchial non-Hodgkin's lymphoma is extremely rare. All patients had disseminated disease at the time of their endobronchial involvement. Chest radiographs revealed hilar masses and/or varying degrees of lobar collapse in
Terry L. Kilgore +2 more
openaire +2 more sources
Pediatric Annals, 1988
The non-Hodgkin's lymphomas are a group of diseases for which substantial progress has been made in understanding tumor biology and effectiveness of treatment during the last few years. These advances may provide insight into the development of neoplasms because of recognized association of lymphomas with viral infections and immunodeficiency.
openaire +2 more sources
The non-Hodgkin's lymphomas are a group of diseases for which substantial progress has been made in understanding tumor biology and effectiveness of treatment during the last few years. These advances may provide insight into the development of neoplasms because of recognized association of lymphomas with viral infections and immunodeficiency.
openaire +2 more sources
Localized non-Hodgkin's lymphoma
European Journal of Cancer (1965), 1980Abstract Radiation was the primary therapy in 100 patients with clinically localized non-Hodgkin's lymphoma. The histological pattern was nodular in 20 and diffuse in 80 . Thirty-five had nodal disease and 65 had extranodal involvement. The predicted 10 yr survival was 64% for stage I and 43% for stage II, with disease free survival of ...
A R, Timothy +3 more
openaire +2 more sources
Current Problems in Cancer, 1996
Lymphoid neoplasia is a complex area comprising multiple diseases with varied pathology, treatment, and outcome. The non-Hodgkin's lymphomas are reviewed here. Non-Hodgkin's lymphomas, collectively, represent the sixth most common cancer in the United States as well as the sixth most common cause of cancer deaths. The overall incidence of non-Hodgkin's
openaire +2 more sources
Lymphoid neoplasia is a complex area comprising multiple diseases with varied pathology, treatment, and outcome. The non-Hodgkin's lymphomas are reviewed here. Non-Hodgkin's lymphomas, collectively, represent the sixth most common cancer in the United States as well as the sixth most common cause of cancer deaths. The overall incidence of non-Hodgkin's
openaire +2 more sources
Follicular non-Hodgkin's lymphoma
Clinical Radiology, 2010Follicular non-Hodgkin's lymphoma (NHL) is a unique subtype of NHL, which is indolent, incurable with a high prevalence of residual mass after treatment, and may transform to more aggressive NHL. The aim of this review is to (1) describe the histological and flow cytometry characteristics of follicular NHL; (2) introduce the Follicular Lymphoma ...
D, Hayashi +7 more
openaire +2 more sources